Biography

Cronos Group entered into a landmark partnership to produce cultured cannabinoids at scale with Ginkgo Bioworks. Using biosynthesis as the means of production, Cronos Group and Ginkgo Bioworks will reduce the cost of pure cannabinoid production, create commercial scale and the ability to access rare cannabinoids, which are key to product differentiation. Cronos Group will have the exclusive right to use and commercialize the key patented intellectual property related to the production of the 8 target cannabinoids perpetually and globally.